Healthcare / Health Information ServicesASX
$0.13
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $1.6M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
41/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$86M
P/E
N/A
•EV/EBITDA
53.7x
↑ROE
-1.7%
↓Gross Margin
81.4%
↑Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-15.0%
FCF CAGR
—
FCF margin
-135.0%
FCF / Net income
37.44x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.3M · net income $-264000.0 · FCF $-9.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.3M | $7.3M | $6.5M | $6.0M | $11.9M |
| Net Income | $-264000.00 | $-264000.00 | $-1.8M | $-1.1M | $252000.00 |
| EBITDA | $1.4M | $1.4M | $1.4M | $329000.00 | $2.5M |
| EPS | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Gross Margin | 81.4% | 81.4% | 81.0% | 79.9% | 88.3% |
| Operating Margin | -19.4% | -19.4% | -21.0% | -12.9% | 2.9% |
| Net Margin | -3.6% | -3.6% | -27.3% | -17.5% | 2.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.02 | 0.00 | 0.01 |
| Current Ratio | 3.68 | 3.68 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-9.9M | $-9.9M | $1.6M | $7.6M | $-694000.00 |
| Returns | |||||
| ROE | -1.7% | -1.7% | -11.1% | -4.7% | 1.1% |
| Valuation | |||||
| P/E | — | — | — | — | 95.00 |
| EV/EBITDA | 53.69 | 53.69 | 9.69 | 28.33 | 6.78 |
| P/B | 4.88 | 4.88 | 1.69 | 0.99 | 0.98 |
| Growth & Yield | |||||
| Revenue Growth | 12.8% | 12.8% | 7.8% | -49.5% | — |
| EPS Growth | 86.7% | 86.7% | -66.7% | -550.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+46.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.00 → -0.00
Residual
+46.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.